CARDIOME PHARMA CORP - COM NO PAR (CRME)

CUSIP: 14159U301

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM NO PAR
Total 13F shares
5,341,110
Share change
-472,672
Total reported value
$42,001,000
Put/Call ratio
138%
Price per share
$7.85
Number of holders
29
Value change
-$3,763,095
Number of buys
15
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 14159U301?
CUSIP 14159U301 identifies CRME - CARDIOME PHARMA CORP - COM NO PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CARDIOME PHARMA CORP - COM NO PAR (CRME) as of Q2 2014

As of 30 Jun 2014, CARDIOME PHARMA CORP - COM NO PAR (CRME) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,341,110 shares. The largest 10 holders included FMR LLC, ADAGE CAPITAL PARTNERS GP LLC, Fortress Investment Group LLC, CLOUGH CAPITAL PARTNERS L P, WESTFIELD CAPITAL MANAGEMENT CO LP, Alistair Capital Management, L.L.C., TURNER INVESTMENTS, L.P., RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and BlackRock Institutional Trust Company, N.A.. This page lists 29 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.